Malorye Allison

821 total citations
37 papers, 584 citations indexed

About

Malorye Allison is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Malorye Allison has authored 37 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Reproductive Medicine. Recurrent topics in Malorye Allison's work include Science, Research, and Medicine (8 papers), Biomedical Ethics and Regulation (4 papers) and CRISPR and Genetic Engineering (4 papers). Malorye Allison is often cited by papers focused on Science, Research, and Medicine (8 papers), Biomedical Ethics and Regulation (4 papers) and CRISPR and Genetic Engineering (4 papers). Malorye Allison collaborates with scholars based in United States. Malorye Allison's co-authors include Sarah Webb, Aaron Bouchie, Laura DeFrancesco and Daniel F. Austin and has published in prestigious journals such as Science, Nature Biotechnology and Bulletin of the Torrey Botanical Club.

In The Last Decade

Malorye Allison

36 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malorye Allison United States 12 205 109 85 81 67 37 584
Shwu‐Luan Lee United States 6 353 1.7× 118 1.1× 103 1.2× 40 0.5× 35 0.5× 7 655
Shareen A. Iqbal United States 13 329 1.6× 156 1.4× 40 0.5× 141 1.7× 32 0.5× 20 835
Anne Pariser United States 17 215 1.0× 49 0.4× 60 0.7× 83 1.0× 229 3.4× 35 782
Annabelle Heier Switzerland 9 278 1.4× 144 1.3× 19 0.2× 61 0.8× 17 0.3× 16 548
Ciska Verbaanderd Belgium 9 216 1.1× 100 0.9× 20 0.2× 34 0.4× 16 0.2× 12 526
Mahdi Jalili Iran 14 380 1.9× 51 0.5× 57 0.7× 62 0.8× 43 0.6× 60 783
Li Zhu China 19 403 2.0× 87 0.8× 48 0.6× 13 0.2× 66 1.0× 54 1.1k
Steffen Ventz United States 14 427 2.1× 176 1.6× 137 1.6× 40 0.5× 77 1.1× 35 943
Sophie Callies United States 20 601 2.9× 321 2.9× 142 1.7× 21 0.3× 39 0.6× 44 1.2k
Ursula Becker Germany 15 124 0.6× 72 0.7× 61 0.7× 44 0.5× 35 0.5× 40 521

Countries citing papers authored by Malorye Allison

Since Specialization
Citations

This map shows the geographic impact of Malorye Allison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malorye Allison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malorye Allison more than expected).

Fields of papers citing papers by Malorye Allison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malorye Allison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malorye Allison. The network helps show where Malorye Allison may publish in the future.

Co-authorship network of co-authors of Malorye Allison

This figure shows the co-authorship network connecting the top 25 collaborators of Malorye Allison. A scholar is included among the top collaborators of Malorye Allison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malorye Allison. Malorye Allison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouchie, Aaron, Malorye Allison, Sarah Webb, & Laura DeFrancesco. (2014). Nature Biotechnology's academic spinouts of 2013. Nature Biotechnology. 32(3). 229–238. 14 indexed citations
2.
Allison, Malorye. (2013). MEK inhibitor nears approval. Nature Biotechnology. 31(1). 4–4. 2 indexed citations
3.
Allison, Malorye. (2013). Genomic testing reaches into the womb. Nature Biotechnology. 31(7). 595–601. 10 indexed citations
4.
Allison, Malorye. (2013). Alliance to bolster translation of academic R&D assets. Nature Biotechnology. 31(4). 275–275. 1 indexed citations
5.
Allison, Malorye. (2013). Gilead widens cancer focus. Nature Biotechnology. 31(2). 90–90. 6 indexed citations
6.
Allison, Malorye. (2012). Clinical setbacks reduce IGF-1 inhibitors to cocktail mixers. Nature Biotechnology. 30(10). 906–907. 16 indexed citations
7.
Allison, Malorye. (2012). Hemacord approval may foreshadow regulatory creep for HSC therapies. Nature Biotechnology. 30(4). 304–304. 16 indexed citations
8.
Allison, Malorye. (2011). Myriad decision reassures biotechs but diagnostics still murky. Nature Biotechnology. 29(9). 771–772. 4 indexed citations
9.
Allison, Malorye. (2010). Avastin's commercial march suffers setback. Nature Biotechnology. 28(9). 879–880. 7 indexed citations
10.
Allison, Malorye. (2010). As Genzyme flounders, competitors and activist investors swoop in. Nature Biotechnology. 28(1). 3–4. 9 indexed citations
11.
Allison, Malorye. (2010). Biomarker-led adaptive trial blazes a trail in breast cancer. Nature Biotechnology. 28(5). 383–384. 6 indexed citations
12.
Allison, Malorye. (2010). Turning the tide in lung cancer. Nature Biotechnology. 28(10). 999–1002. 5 indexed citations
13.
Allison, Malorye. (2010). PML problems loom for Rituxan. Nature Biotechnology. 28(2). 105–106. 18 indexed citations
14.
Allison, Malorye. (2010). The HER2 testing conundrum. Nature Biotechnology. 28(2). 117–119. 49 indexed citations
15.
Allison, Malorye. (2009). Illumina's cut-price genome scan. Nature Biotechnology. 27(8). 685–685. 2 indexed citations
16.
Allison, Malorye. (2009). Can web 2.0 reboot clinical trials?. Nature Biotechnology. 27(10). 895–902. 46 indexed citations
17.
Allison, Malorye. (2009). Regulation of consumer genomic tests remains in limbo. Nature Biotechnology. 27(10). 875–877. 3 indexed citations
18.
Allison, Malorye. (2009). Genzyme backs Osiris, despite Prochymal flop. Nature Biotechnology. 27(11). 966–967. 83 indexed citations
19.
Allison, Malorye. (2008). Industry welcomes Genetic Information Nondiscrimination Act. Nature Biotechnology. 26(6). 596–597. 5 indexed citations
20.
Austin, Daniel F., et al.. (1992). Ethnobotany of Aublet's Histoire Des Plantes de La Guiane Francoise (1775).. Bulletin of the Torrey Botanical Club. 119(2). 216–216. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shwu‐Luan Lee Breakdown of academic impact, for papers by Shareen A. Iqbal Breakdown of academic impact, for papers by Anne Pariser Breakdown of academic impact, for papers by Annabelle Heier Breakdown of academic impact, for papers by Ciska Verbaanderd Breakdown of academic impact, for papers by Mahdi Jalili Breakdown of academic impact, for papers by Li Zhu Breakdown of academic impact, for papers by Steffen Ventz Breakdown of academic impact, for papers by Sophie Callies Breakdown of academic impact, for papers by Ursula Becker
Rankless by CCL
2026